|
IT1094076B
(it)
|
1978-04-18 |
1985-07-26 |
Acraf |
Cicloalchiltriazoli
|
|
US4508715A
(en)
|
1981-07-01 |
1985-04-02 |
University Of Georgia Research Foundation, Inc. |
Antagonism of central nervous system drugs by the administration of 4-aminopyridine alone or in combination with other drugs
|
|
US4443441A
(en)
|
1981-08-07 |
1984-04-17 |
Galin Miles A |
Fixation of intraocular lenses
|
|
US4629456A
(en)
|
1981-09-18 |
1986-12-16 |
Edwards David L |
Target ring for an eye dropper bottle
|
|
US4515295A
(en)
|
1983-09-06 |
1985-05-07 |
St. Luke's Hospital |
Eye dropper with light source
|
|
US4590202A
(en)
|
1984-01-19 |
1986-05-20 |
Merck & Co., Inc. |
N-(2-imidazolidinylidene)-5H-dibenzo[a,d]cyclohepten-5-amine compounds and α2 -adrenergic antagonistic uses thereof
|
|
US4659714A
(en)
|
1984-03-27 |
1987-04-21 |
Dentsply, Ltd. |
Anesthetic methods for mammals
|
|
US4906613A
(en)
|
1985-11-05 |
1990-03-06 |
Schering Corporation |
Antiglaucoma compositions and methods
|
|
IE60588B1
(en)
|
1986-07-30 |
1994-07-27 |
Sumitomo Pharma |
Carbapenem compound in crystalline form, and its production and use
|
|
US5032392A
(en)
|
1986-09-04 |
1991-07-16 |
Vision Pharmaceuticals |
Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
|
|
US4938970A
(en)
|
1987-02-06 |
1990-07-03 |
Hustead Robert E |
Painless electrolyte solutions
|
|
US4834727A
(en)
|
1987-12-08 |
1989-05-30 |
Cope Samuel M |
Eye dropper bottle attachment for post-surgical and general use
|
|
US5149320A
(en)
|
1988-04-11 |
1992-09-22 |
Dhaliwal Avtar S |
Composite anesthetic article and method of use
|
|
US5261903A
(en)
|
1988-04-11 |
1993-11-16 |
M.D. Inc. |
Composite anesthetic article and method of use
|
|
US5281591A
(en)
|
1989-05-22 |
1994-01-25 |
Allergan, Inc. |
Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
|
|
FR2647675B1
(fr)
|
1989-06-05 |
1994-05-20 |
Sanofi |
Utilisation d'un derive de la statine dans le traitement des affections oculaires
|
|
US5447912A
(en)
|
1989-09-18 |
1995-09-05 |
Senetek, Plc |
Erection-inducing methods and compositions
|
|
US5059188A
(en)
|
1990-03-28 |
1991-10-22 |
Goddard Larry C |
Eye dropper attachment
|
|
US5192527A
(en)
|
1991-07-01 |
1993-03-09 |
Abrahmsohn Glenn M |
Method of reversing local anesthesia and reagent system therefor
|
|
EP0648118A1
(en)
|
1992-07-02 |
1995-04-19 |
Telor Ophthalmic Pharmaceuticals, Inc. |
Methods and products for treating presbyopia
|
|
US5288759A
(en)
|
1992-08-27 |
1994-02-22 |
Alcon Laboratories, Inc. |
Use of certain sulfamoyl-substituted phenethylamine derivatives to reverse drug-induced mydriasis
|
|
US5514118A
(en)
|
1992-12-23 |
1996-05-07 |
Kummer; Frederick J. |
Measured dose eye dropper
|
|
CA2125060C
(en)
|
1993-07-02 |
1999-03-30 |
Henry P. Dabrowski |
Ophthalmic solution for artificial tears
|
|
WO1996011003A1
(en)
|
1994-10-10 |
1996-04-18 |
Novartis Ag |
Ophthalmic and aural compositions containing diclofenac potassium
|
|
US5792767A
(en)
|
1995-01-27 |
1998-08-11 |
Abbott Laboratories |
Bicyclic substituted hexahydrobenz e! isoindole alpha-1 adrenergic antagonists
|
|
US5731339A
(en)
|
1995-04-28 |
1998-03-24 |
Zonagen, Inc. |
Methods and formulations for modulating the human sexual response
|
|
US5584823A
(en)
|
1995-07-20 |
1996-12-17 |
Ontario Incorporated |
Illuminated eye dropper device
|
|
US6106866A
(en)
|
1995-07-31 |
2000-08-22 |
Access Pharmaceuticals, Inc. |
In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
|
|
US5627611A
(en)
|
1995-12-29 |
1997-05-06 |
Scheiner; Stanley A. |
Artificial tears
|
|
ZA97452B
(en)
|
1996-01-25 |
1997-08-15 |
Trinity College Dublin |
Streptococcus equi vaccine.
|
|
US6469065B1
(en)
|
1996-02-02 |
2002-10-22 |
Nitromed, Inc. |
Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
|
|
CA2279651A1
(en)
|
1996-09-05 |
1998-03-12 |
Massachusetts Institute Of Technology |
Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
|
|
KR100195348B1
(ko)
|
1996-10-31 |
1999-06-15 |
장용택 |
안정한 프로스타글란딘 e1-함유 주사제 조성물
|
|
US5891882A
(en)
|
1996-12-06 |
1999-04-06 |
Abbott Laboratories |
Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds
|
|
WO1999007353A1
(en)
|
1997-08-05 |
1999-02-18 |
The Mount Sinai School Of Medicine Of The City University Of New York |
USE OF α1A-ADRENERGIC RECEPTOR ANTAGONISTS IN GLAUCOMA THERAPY
|
|
US6001845A
(en)
|
1998-06-19 |
1999-12-14 |
Schering Corporation |
Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
|
|
US5885550A
(en)
|
1998-07-02 |
1999-03-23 |
Vallier; Deandra K. |
Ophthalmic whitening solution
|
|
US8889112B2
(en)
|
1999-09-16 |
2014-11-18 |
Ocularis Pharma, Llc |
Ophthalmic formulations including selective alpha 1 antagonists
|
|
AU7581000A
(en)
|
1999-09-16 |
2001-04-17 |
Gerald D. Horn |
A method for optimizing pupil size using alpha antagonist
|
|
US20020082288A1
(en)
|
1999-09-16 |
2002-06-27 |
Gerald Horn |
Ophthalmic formulations comprising an imidazoline
|
|
US6730065B1
(en)
|
2000-09-15 |
2004-05-04 |
Ocularis Pharma, Inc. |
Night vision composition
|
|
US6420407B1
(en)
*
|
1999-09-16 |
2002-07-16 |
Gerald Horn |
Ophthalmic formulation which modulates dilation
|
|
US6730691B1
(en)
|
2000-02-10 |
2004-05-04 |
Miles A. Galin |
Uses of alpha adrenergic blocking agents
|
|
DE60126265T2
(de)
|
2000-05-12 |
2007-10-31 |
Novalar Pharmaceuticals, Inc. |
Zusammensetzung bestehend aus Phentolaminmesylat und deren Verwendung
|
|
US6623765B1
(en)
|
2000-08-01 |
2003-09-23 |
University Of Florida, Research Foundation, Incorporated |
Microemulsion and micelle systems for solubilizing drugs
|
|
US20060211753A1
(en)
|
2000-11-03 |
2006-09-21 |
Ocularis Pharma, Inc. |
Method and composition which reduces stimulation of muscles which dilate the eye
|
|
US6515006B2
(en)
*
|
2000-11-08 |
2003-02-04 |
Hmt Pharma, Inc. |
Ophthalmic formulation which modulates dilation
|
|
US7229630B2
(en)
|
2002-06-20 |
2007-06-12 |
Novalar Pharmaceuticals, Inc. |
Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
|
|
US20030236306A1
(en)
|
2002-06-20 |
2003-12-25 |
Chen Andrew X. |
Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
|
|
US7148211B2
(en)
|
2002-09-18 |
2006-12-12 |
Genzyme Corporation |
Formulation for lipophilic agents
|
|
US8648213B2
(en)
|
2004-10-06 |
2014-02-11 |
Allergan, Inc. |
Prostamides for the treatment of glaucoma and related diseases
|
|
US7868035B2
(en)
|
2005-02-01 |
2011-01-11 |
Allergan, Inc. |
Therapeutic esters
|
|
US20060257388A1
(en)
|
2005-05-13 |
2006-11-16 |
Julius Knowles |
Drug delivery systems for stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
|
|
WO2007008666A2
(en)
|
2005-07-08 |
2007-01-18 |
Ocularis Pharma, Inc. |
Compositions and methods for improving vision using adherent thin films
|
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
|
WO2008009141A1
(en)
|
2006-07-21 |
2008-01-24 |
Queen's University At Kingston |
Methods and therapies for potentiating a therapeutic action of an alpha- 2 adrenergic receptor agonist and inhibiting and/or reversing tolerance to alpha- 2 adrenergic receptor agonists
|
|
EP2044951A1
(en)
|
2007-10-02 |
2009-04-08 |
Merz Pharma GmbH & Co. KGaA |
The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases
|
|
US20090131303A1
(en)
|
2007-11-16 |
2009-05-21 |
Bor-Shyue Hong |
Methods and compositions for treating dry eye
|
|
GB0724558D0
(en)
*
|
2007-12-15 |
2008-01-30 |
Sharma Anant |
Optical correction
|
|
US20090220618A1
(en)
|
2008-02-29 |
2009-09-03 |
Erning Xia |
Pharmaceutical formulations comprising polyanionic materials and source of hydrogen peroxide
|
|
ES2443548T5
(es)
|
2008-03-17 |
2020-01-23 |
Alcon Res Ltd |
Composiciones farmacéuticas acuosas que contienen complejos de borato-poliol
|
|
US20100028266A1
(en)
|
2008-08-01 |
2010-02-04 |
Alpha Synergy Development. Inc. |
Composition and methods for treating allergic response
|
|
CN101463009B
(zh)
|
2009-01-14 |
2010-09-22 |
天津市中央药业有限公司 |
一种甲磺酸酚妥拉明的合成方法
|
|
US8299079B2
(en)
|
2009-05-22 |
2012-10-30 |
Kaufman Herbert E |
Preparations and methods for ameliorating or reducing presbyopia
|
|
US20100298335A1
(en)
*
|
2009-05-22 |
2010-11-25 |
Kaufman Herbert E |
Preparations and Methods for Ameliorating or Reducing Presbyopia
|
|
TWI489997B
(zh)
|
2009-06-19 |
2015-07-01 |
Alcon Res Ltd |
含有硼酸－多元醇錯合物之水性藥學組成物
|
|
US20130143938A1
(en)
|
2009-07-27 |
2013-06-06 |
Eye Therapies Llc |
Compositions and Methods for the Treatment of Migraine
|
|
US20110178147A1
(en)
|
2009-10-20 |
2011-07-21 |
Allergan, Inc. |
Compositions and methods for controlling pupil dilation
|
|
US20120238615A1
(en)
|
2009-10-21 |
2012-09-20 |
Allergan, Inc. |
Alpha adrenergic receptor modulators
|
|
US8883838B2
(en)
|
2010-12-03 |
2014-11-11 |
Allergan, Inc. |
Pharmaceutical cream compositions and methods of use
|
|
US8445526B2
(en)
|
2011-02-03 |
2013-05-21 |
Glaucoma & Nasal Therapies Llc |
Compositions and methods for treatment of glaucoma
|
|
US20130172357A1
(en)
|
2011-02-03 |
2013-07-04 |
Eye Therapies Llc |
Compositions and Methods for Treatment of Glaucoma
|
|
JP6225030B2
(ja)
|
2011-02-15 |
2017-11-01 |
アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ |
酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物
|
|
CA2829040A1
(en)
|
2011-03-03 |
2012-09-07 |
Allergan, Inc. |
Non-aqueous silicone-based ophthalmic formulations
|
|
WO2012149381A1
(en)
|
2011-04-28 |
2012-11-01 |
Alpha Synergy Development, Inc. |
Compositions and methods for improving night vision
|
|
US20130029919A1
(en)
|
2011-07-26 |
2013-01-31 |
Allergan, Inc. |
Two part formulation system for opthalmic delivery
|
|
EP2809300A1
(en)
|
2012-02-02 |
2014-12-10 |
Glaucoma & Nasal Therapies LLC |
Compositions and methods for treatment of glaucoma
|
|
EP2819674A2
(en)
|
2012-02-27 |
2015-01-07 |
Eye Therapies LLC |
Compositions and methods for the treatment of migraine
|
|
US10507245B2
(en)
|
2012-07-19 |
2019-12-17 |
Luis Felipe Vejarano Restrepo |
Ophthalmic formulation and method for ameliorating presbyopia
|
|
AU2013201465B2
(en)
*
|
2012-10-24 |
2016-03-03 |
Rayner Surgical (Ireland) Limited |
Stable preservative-free mydriatic and anti-inflammatory solutions for injection
|
|
AU2014212275B2
(en)
|
2013-02-01 |
2018-09-06 |
Ocuphire Pharma, Inc. |
Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
|
|
AU2014212274A1
(en)
*
|
2013-02-01 |
2015-08-13 |
Ocularis Pharma, Llc |
Aqueous ophthalmic solutions of phentolamine and medical uses thereof
|
|
US8597629B1
(en)
|
2013-06-21 |
2013-12-03 |
Premium Ocular Solutions LLC. |
Artificial tear compositions comprising a combination of nonionic surfactants
|
|
US10064818B2
(en)
|
2013-08-28 |
2018-09-04 |
Presbyopia Therapies, LLC |
Compositions and methods for the treatment of presbyopia
|
|
US9968594B2
(en)
|
2013-08-28 |
2018-05-15 |
Presbyopia Therapies Llc |
Compositions and methods for the treatment of presbyopia
|
|
CA3031370A1
(en)
*
|
2016-08-19 |
2018-02-22 |
Orasis Pharmaceuticals Ltd. |
Ophthalmic pharmaceutical compositions and uses relating thereto
|
|
HRP20220762T1
(hr)
|
2018-04-24 |
2022-09-16 |
Allergan, Inc. |
Upotreba pilokarpin-hidroklorida u liječenju prezbiopije
|
|
WO2020087021A1
(en)
|
2018-10-26 |
2020-04-30 |
Ocuphire Pharma, Inc. |
Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders
|